| BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder CancerTumor BMP4 Induces M2 Polarization Favoring BC Progression VG Martínez, C Rubio, M Martínez-Fernández, C Segovia, ... Clinical Cancer Research 23 (23), 7388-7399, 2017 | 183 | 2017 |
| Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression C Segovia, E San José-Enériz, E Munera-Maravilla, ... Nature medicine 25 (7), 1073-1081, 2019 | 159 | 2019 |
| CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status C Rubio, M Martínez-Fernández, C Segovia, I Lodewijk, ... Clinical Cancer Research 25 (1), 390-402, 2019 | 64 | 2019 |
| DUTRENEO Trial: A randomized phase II trial of DUrvalumab and TREmelimumab versus chemotherapy as a NEOadjuvant approach to muscle-invasive urothelial bladder cancer (MIBC … E Grande, F Guerrero, J Puente, I Galante, I Duran, M Dominguez, ... Journal of Clinical Oncology 38 (15_suppl), 5012-5012, 2020 | 61 | 2020 |
| Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long‐term outcomes comparable to standard criteria donation after brain death M Molina, F Guerrero‐Ramos, M Fernández‐Ruiz, E González, J Cabrera, ... American Journal of Transplantation 19 (2), 434-447, 2019 | 60 | 2019 |
| Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized … F Guerrero-Ramos, DA González-Padilla, A González-Díaz, ... World journal of urology 40 (4), 999-1004, 2022 | 47 | 2022 |
| Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future M Rey-Cárdenas, F Guerrero-Ramos, AG de Liaño Lista, ... Cancer Treatment Reviews 93, 102142, 2021 | 41 | 2021 |
| Infecciones urinarias adquiridas en la comunidad que requieren hospitalización: factores de riesgo, características microbiológicas y resistencia a antibióticos J Medina-Polo, F Guerrero-Ramos, S Pérez-Cadavid, A Arrébola-Pajares, ... Actas Urológicas Españolas 39 (2), 104-111, 2015 | 36 | 2015 |
| Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC) M Álvarez-Maestro, F Guerrero-Ramos, O Rodríguez-Faba, ... Actas Urológicas Españolas (English Edition) 45 (2), 93-102, 2021 | 35 | 2021 |
| Healthcare-associated infections in a department of urology: Incidence and patterns of antibiotic resistance J Medina-Polo, E Jiménez-Alcaide, L García-González, ... Scandinavian journal of urology 48 (2), 203-209, 2014 | 31 | 2014 |
| Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes JD Subiela, OR Faba, FG Ramos, HV Reyes, F Pisano, A Breda, J Palou European urology focus 6 (4), 674-682, 2020 | 29 | 2020 |
| Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance E Jiménez-Alcaide, J Medina-Polo, L García-González, ... Archivos espanoles de urologia 68 (6), 541-550, 2015 | 29 | 2015 |
| Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain A Plata, F Guerrero-Ramos, C Garcia, A González-Díaz, ... Journal of Clinical Medicine 10 (21), 5105, 2021 | 28 | 2021 |
| Intravesical chemohyperthermia vs. Bacillus Calmette-Guerin instillation for intermediate-and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis H Zhao, VWS Chan, D Castellani, EOT Chan, WLK Ong, Q Peng, ... Frontiers in Surgery 8, 775527, 2021 | 24 | 2021 |
| Community-associated urinary infections requiring hospitalization: Risk factors, microbiological characteristics and patterns of antibiotic resistance J Medina-Polo, F Guerrero-Ramos, S Pérez-Cadavid, A Arrébola-Pajares, ... Actas Urológicas Españolas (English Edition) 39 (2), 104-111, 2015 | 24 | 2015 |
| Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia DA González-Padilla, A González-Díaz, F Guerrero-Ramos, ... Urologic Oncology: Seminars and Original Investigations 39 (1), 76. e9-76. e14, 2021 | 22 | 2021 |
| Laparoscopic approach for Wilms tumor DC Barbancho, FG Ramos, FL Vázquez, AA Bramtot, AG Fraile Surgical Laparoscopy Endoscopy & Percutaneous Techniques 24 (1), 22-25, 2014 | 21 | 2014 |
| Survey of satisfaction in hospitalized patients at a urology department. A Arrebola-Pajares, A Tejido-Sanchez, E Jiménez-Alcaide, J Medina-Polo, ... Archivos espanoles de urologia 67 (7), 621-627, 2014 | 16 | 2014 |
| Safety, tolerability, and preliminary efficacy of TAR-200 in patients with muscle-invasive bladder cancer who refused or were unfit for curative-intent therapy: a phase 1 study MD Tyson, D Morris, J Palou, O Rodriguez, MC Mir, RJ Dickstein, ... The Journal of Urology 209 (5), 890-900, 2023 | 15 | 2023 |
| LBA104 First safety and efficacy results of the TAR-210 erdafitinib (erda) intravesical delivery system in patients (pts) with non–muscle-invasive bladder cancer (NMIBC) with … A Vilaseca, G Jayram, C Raventos, ND Shore, D Zainfeld, TW Kang, ... Annals of Oncology 34, S1343, 2023 | 14 | 2023 |
Jesus M ParamioMolecular Oncology Unit CIEMAT and Biomedical Res. Inst. Univ Hosp."12 de Octubre"Email verificata su ciemat.es